---
audienceLevel: patient
cancerTypes:
- pancreatic
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Belzutifan - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/belzutifan
version: v1
---

# Belzutifan - NCI

# Belzutifan

Placeholder slot

(bel-ZOO-tih-fan)

This page contains brief information about belzutifan and a collection of links to more information about the use of
this drug, research results, and ongoing clinical trials.

US Brand Name(s)

Welireg

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=13e15ee0-d679-4fa9-9430-e2e2170474da&audience=consumer)

## Use in Cancer

Belzutifan is approved to treat adults with:

- Cancers linked to **[von Hippel-Lindau disease](/Common/PopUps/popDefinition.aspx?id=794341&version=Patient&language=English)** that require treatment but not immediate surgery, including:
- [Central nervous system](/Common/PopUps/popDefinition.aspx?id=427310&version=Patient&language=English) hemangioblastoma.
- [Pancreatic neuroendocrine tumors](/Common/PopUps/popDefinition.aspx?id=753531&version=Patient&language=English).
- [Renal cell carcinoma](/Common/PopUps/popDefinition.aspx?id=661352&version=Patient&language=English).
- **Renal Cell Carcinoma** that is [advanced](/Common/PopUps/popDefinition.aspx?id=478743&version=Patient&language=English). It is used in patients who have been treated with anti-[VEGF](/Common/PopUps/popDefinition.aspx?id=44474&version=Patient&language=English) therapy and either anti-[PD-1](/Common/PopUps/popDefinition.aspx?id=777027&version=Patient&language=English) or anti-[PD-L1](/Common/PopUps/popDefinition.aspx?id=797389&version=Patient&language=English) therapy.

Belzutifan is also being studied in the treatment of other types of cancer.

## More About Belzutifan

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/788947) - Detailed scientific definition and other names for this drug.

MedlinePlus Information on [Belzutifan](https://medlineplus.gov/druginfo/meds/a621047.html) - A lay language summary of important information about this drug that may include the following:

- warnings about this drug,
- what this drug is used for and how it is used,
- what you should tell your doctor before using this drug,
- what you should know about this drug before using it,
- other drugs that may interact with this drug, and
- possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

## Research Results and Related Resources

[Targeted Therapy to Treat Cancer](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

[Belzutifan Approved to Treat Tumors Linked to Inherited Disorder VHL](https://www.cancer.gov/news-events/cancer-currents-blog/2021/fda-belzutifan-vhl-tumors)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Belzutifan](https://www.cancer.gov/research/participate/clinical-trials/intervention/C135627) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
